Neupax 20

Array
(
    [ID] => 1310
    [post_author] => 16
    [post_date] => 2012-06-25 14:45:26
    [post_date_gmt] => 2012-06-25 14:45:26
    [post_content] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:
Fluoxetina (como Fluoxetina Clorhidrato) 20 mg
Acción Terapéutica:
Antidepresivo.
Indicaciones:
Neupax está indicado para:

 	
El tratamiento agudo y de mantenimiento del trastorno depresivo mayor.
 	
El tratamiento agudo y de mantenimiento de las obsesiones y compulsiones en pacientes con trastorno obsesivo-compulsivo (TOC).
 	
El tratamiento agudo y de mantenimiento de los episodios de ingesta excesiva de alimentos (atracones) y vómitos en pacientes con bulimia nerviosa moderada a severa.
 	
El tratamiento del trastorno disfórico premenstrual (TDPM).

 
Presentaciones:
Envase conteniendo 30 comprimidos recubiertos.
    [post_title] => Neupax 20
    [post_excerpt] => Antidepresivo.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => neupax
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2025-07-07 10:02:09
    [post_modified_gmt] => 2025-07-07 13:02:09
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1310
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 20023
                    [post_author] => 16
                    [post_date] => 2025-07-07 09:59:14
                    [post_date_gmt] => 2025-07-07 12:59:14
                    [post_content] => 
                    [post_title] => NEUPAX Información Paciente Disp. 7499-20 (2)
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => neupax-informacion-paciente-disp-7499-20-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-07-07 09:59:14
                    [post_modified_gmt] => 2025-07-07 12:59:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2025/07/NEUPAX-Informacion-Paciente-Disp.-7499-20-2.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 20022
                    [post_author] => 16
                    [post_date] => 2025-07-07 09:59:11
                    [post_date_gmt] => 2025-07-07 12:59:11
                    [post_content] => 
                    [post_title] => NEUPAX Prospecto Disp. 7499-20 (2)
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => neupax-prospecto-disp-7499-20-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-07-07 09:59:11
                    [post_modified_gmt] => 2025-07-07 12:59:11
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2025/07/NEUPAX-Prospecto-Disp.-7499-20-2.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 13543
                    [post_author] => 16
                    [post_date] => 2017-11-02 10:14:05
                    [post_date_gmt] => 2017-11-02 13:14:05
                    [post_content] => 
                    [post_title] => neupax-banner
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => neupax-banner
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2017-11-02 10:14:05
                    [post_modified_gmt] => 2017-11-02 13:14:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/11/neupax-banner.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Neupax
        )

    [principio_activo] => Array
        (
            [0] => Fluoxetina
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:

Fluoxetina (como Fluoxetina Clorhidrato) 20 mg
Acción Terapéutica:
Antidepresivo.
Indicaciones:
Neupax está indicado para:

El tratamiento agudo y de mantenimiento del trastorno depresivo mayor.
El tratamiento agudo y de mantenimiento de las obsesiones y compulsiones en pacientes con trastorno obsesivo-compulsivo (TOC).
El tratamiento agudo y de mantenimiento de los episodios de ingesta excesiva de alimentos (atracones) y vómitos en pacientes con bulimia nerviosa moderada a severa.
El tratamiento del trastorno disfórico premenstrual (TDPM).

 
Presentaciones:
Envase conteniendo 30 comprimidos recubiertos.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/NEUPAX-Prospecto-Disp.-7499-20-2.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:373165;}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2025/07/NEUPAX-Informacion-Paciente-Disp.-7499-20-2.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:658373;}
        )

)

anexo_congre_single